-
1 Comment
Surgical Innovations Group plc is currently in a long term uptrend where the price is trading 11.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Finally, its free cash flow grew by 38.4% to $252K since the same quarter in the previous year.
Based on the above factors, Surgical Innovations Group plc gets an overall score of 3/5.
ISIN | GB0004016704 |
---|---|
Sector | Healthcare |
Exchange | LSE |
CurrencyCode | GBP |
Industry | Medical Devices |
Beta | 0.22 |
---|---|
Market Cap | 6M |
PE Ratio | None |
Target Price | 1.9 |
Dividend Yield | None |
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite port access systems; YelloPort +plus Resposable port access systems; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes specialist medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SUN.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025